Filter
2384
Filtered Results: 2384
Text search:
World
Health
Organization
(South-East
Asia)
Featured
Recommendations
200
New Publications
588
Language
Document type
No document type
1243
Studies & Reports
601
Guidelines
238
Manuals
111
Strategic & Response Plan
78
Fact sheets
32
Training Material
29
Situation Updates
23
Resource Platforms
15
Infographics
9
Online Courses
3
Brochures
2
Countries / Regions
Global
171
India
96
South–East Asia Region
87
Myanmar / Burma
84
Nepal
64
Bangladesh
50
Asia
50
Indonesia
39
Philippines
38
Africa
36
Western and Central Europe
31
Cambodia
29
Ethiopia
23
South Africa
23
Kenya
22
Uganda
21
Nigeria
19
Syria
19
Middle East and North Africa
18
Thailand
16
Western Pacific Region
16
Tanzania
15
Pakistan
14
Latin America and the Carribbean
14
Liberia
13
Congo, Democratic Republic of
13
Zambia
13
West and Central Africa
13
East and Southern Africa
12
Ghana
11
Afghanistan
11
Malawi
11
Mozambique
11
Eastern Europe
11
Haiti
10
China
10
Ukraine
10
Yemen
10
Rwanda
9
Russia
9
Vietnam
9
Zimbabwe
8
South Sudan
8
Brazil
8
Sierra Leone
7
Laos
7
Senegal
6
Somalia
6
Sri Lanka
6
Eastern Europe and Central Asia
6
Cameroon
5
Sudan
5
Burkina Faso
4
Jordan
4
Malaysia
4
Central African Republic
4
Madagascar
4
Venezuela
4
Timor Leste/ East Timor
4
Moldova
4
Iran
4
Japan
4
Guinea
3
USA
3
Egypt
3
Papua New Guinea
3
Namibia
3
North Macedonia
3
Botswana
3
Albania
3
Georgia
3
Bosnia and Herzegovina
3
Mali
2
Iraq
2
Lebanon
2
Turkey
2
Eswatini/ Swaziland
2
Serbia
2
Croatia
2
Colombia
2
Mexico
2
North Korea
2
Italy
2
Tajikistan
2
Kyrgyzstan
2
Kazakhstan
2
Turkmenistan
2
Belarus
2
Morocco
1
Saudi Arabia
1
Niger
1
Singapore
1
Benin
1
Vanuatu
1
Argentina
1
Peru
1
Hungary
1
Honduras
1
Ecuador
1
Bolivia
1
Greece
1
Libya
1
Angola
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Romania
1
Gabon
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
583
Clinical Guidelines
260
Public Health
176
Women & Child Health
161
Key Resources
122
Capacity Building
51
Pharmacy & Technologies
29
Toolboxes
HIV
237
Mental Health
211
Planetary Health
170
COVID-19
151
TB
115
NTDs
104
AMR
95
Rapid Response
85
Disability
84
Global Health Education
76
NCDs
58
Refugee
53
Caregiver
51
Natural Hazards
40
Conflict
39
Health Financing Toolbox
39
Pharmacy
33
Zika
28
Ebola
21
Polio
16
Cholera
14
Specific Hazards
9
Typhoon
3
Social Ethics
2
Health Financing
1
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Pr...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundament...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over...
The document provides inforation on tobacco use (health effects, quitting, benefits of quitting, e-cigarettes etc.) in a descriptive way.
Worldwide, there are about 17 million deaths due to cardiovascular disease (CVD) each year and at least two or three times as many non-fatal events. Raised cholesterol greatly increases the risks of stroke and heart disease, causing a large
health ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment cri...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public ... problem, one of four priority noncommunicable diseases (NCDs) targeted for action by world leaders. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria tar...
Alcohol use is deeply embedded in the social landscape of many societies, and some 2300 million people drink alcoholic beverages in most parts of the world. At the same time, more than half of the global population aged 15 years and older reported h...
The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary for effective communication and engagement with communities before, during and after public health...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
interim guidance, 25 November 2024
беларускі - Belorussian
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health...
